OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (RPHM)

CUSIP: 75974E103

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
+1,278,895
Put/Call ratio
29%
SEC-reported price per share
$7.62
Number of holders
58
Value change
+$9,846,745
Number of buys
31
Open additional details 1 more signal available
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,305,653

Security key

75974E103

Report period

Q3 2023

Institutions

58

Top holders

10

Ownership snapshot

Top reported holders of RPHM - OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Novo Holdings A/S
Disclosed value leader
NEA Management Company, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F 3/4/5 Highest disclosed value: $28,253,557 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

NEA Management Company, LLC has the largest disclosed position value at $28.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEA Management Company, LLC's linked filing trail.
Disclosed position value Top 5
Novo Holdings A/S $21.85M
NEA Management Company, LLC $28.25M
Carlyle Group Inc. $17.68M
RiverVest Venture Management LLC $16.62M
Octagon Capital Advisors LP $15.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Novo Holdings A/S
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$21,847,273
3,330,377 shares
— 30 Jun 2023
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$28,253,557
4,785,494 shares
— 30 Jun 2023
Carlyle Group Inc.
13F
Company
13F
—
denominator unverified
$17,678,168
2,698,957 shares
— 30 Jun 2023
RiverVest Venture Management LLC
13F
Company
13F
—
denominator unverified
$16,624,483
2,534,220 shares
— 30 Jun 2023
Octagon Capital Advisors LP
13F
Company
13F
—
denominator unverified
$15,537,931
2,368,587 shares
— 30 Jun 2023
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$11,480,000
1,750,000 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
58
Shares
27,359,074
Rows available
58
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q3 2023 holders
58
Holder diff
57
Investor Q4 2025 Shares Q3 2023 Shares Share Diff Share Chg % Q4 2025 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .